Facing The Upcoming Loss Of Blockbuster Drug's Patent Protections, AbbVie Buys Allergan In Mega $63B Deal - Kaiser Health News
Facing The Upcoming Loss Of Blockbuster Drug's Patent Protections, AbbVie Buys Allergan In Mega $63B Deal Kaiser Health News
This is the age of blockbusters,” said David Maris, an analyst for Wells Fargo who follows the drug industry. “And when blockbusters start to go away, companies ...
Comments
Post a Comment